Key facts
- This page summarizes Catherine J. Mackey's Form 4 filing for Avid Bioservices, Inc..
- 5 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 07 Feb 2025, 19:39.
Catherine J. Mackey - 05 Feb 2025 Form 4 Insider Report for Avid Bioservices, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 05 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 Feb 2025, 19:39:04 UTC
- Prior SEC filing
- 17 Dec 2024
- Next SEC filing
- 04 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Stephen Hedberg, by Power of Attorney for Catherine J. Mackey, Ph.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Catherine J. Mackey filed Form 4 for Avid Bioservices, Inc. on 07 Feb 2025.
Change
- Previous filing in this sequence was filed on 17 Dec 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDMO
transaction
Common Stock, $0.001 par value
Disposed to Issuer
- Transaction value
- Shares
- -43,379
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CDMO
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -32,100
- Change %
- -52%
- Price
- Shares after
- 29,705
- Date
- 05 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,100
- Exercise price
- $6.38
- Footnotes
- F3, F4
CDMO
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -19,675
- Change %
- -66%
- Price
- Shares after
- 10,030
- Date
- 05 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,675
- Exercise price
- $6.87
- Footnotes
- F3, F4
CDMO
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -10,030
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,030
- Exercise price
- $10.72
- Footnotes
- F3, F4
CDMO
transaction
Derivative
Restricted Stock Units
Disposed to Issuer
- Transaction value
- Shares
- -8,147
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 05 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,147
- Exercise price
- $0.000000
- Footnotes
- F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Catherine J. Mackey is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub.
Footnote F2
At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
Footnote F3
Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
Footnote F4
This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement.
Footnote F5
Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
Footnote F6
At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement.
SEC remarks
The foregoing descriptions in the footnotes to this Form 4 are qualified in their entirety by reference to the terms of the Merger Agreement. In the event of any conflict between the descriptions above and the terms set forth in the Merger Agreement, the terms set forth in the Merger Agreement shall control.